The global Chemotherapy-Induced Nausea and Vomiting Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant
Segment by Application
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists
The Chemotherapy-Induced Nausea and Vomiting Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Chemotherapy-Induced Nausea and Vomiting Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.
Table of content
1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Scope
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Trends (2016-2027)
2 Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Forecasts by Region
2.1 Global Chemotherapy-Indu
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/